Get started

Financials · BKYI

BIO-key International Inc. (BKYI) financials

For the twelve months ended Jun 30, 2026, BIO-key International Inc. reported $6.70M of revenue and -$6.04M of net income.

Revenue, TTM
$6.70M
Revenue growth, YoY
-3.1%
Net income, TTM
-$6.04M
Net margin
-90.1%
Free cash flow, TTM
-$4.16M
Cash
$1.38M
P/S
0.72
Market cap
$4.8M
Annual revenue$5.94M
FY2016FY2025
Annual net income-$7.16M
FY2016FY2025
Annual free cash flow-$4.68M
FY2016FY2025

BKYI revenue and earnings growth

BKYI revenueQ2 2026$1.92M

Quarter YoY
+13.1%
QoQ
-10.5%
FY YoY
-14.3%
5Y CAGR
+15.9%
10Y CAGR
+1.2%

BKYI revenue was $1.92M in fiscal Q2 2026 (ended Jun 30, 2026), up 13.1% from a year earlier and down 10.5% from the prior quarter. For the full fiscal 2025 it was $5.94M, down 14.3% from fiscal 2024. Compound annual growth was +15.9% over 5 years and +1.2% over 10 years. It rose in 5 of the last 10 fiscal years.

BKYI net incomeQ2 2026-$576.9K

BKYI net income was -$576.9K in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$1.17M a year earlier. For the full fiscal 2025 it was -$7.16M, compared with -$4.30M in fiscal 2024.

BKYI free cash flowQ2 2026-$845.7K

BKYI free cash flow was -$845.7K in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$881.5K a year earlier. For the full fiscal 2025 it was -$4.68M, compared with -$2.93M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue$5.94M$6.93M$7.75M$7.02M$5.11M$2.84M$2.27M$4.04M$6.30M$2.98M
Cost of revenue$1.37M$1.29M$6.32M$2.44M$1.67M$794.8K$2.46M$4.16M$3.24M$729.7K
Gross profit$4.56M$5.64M$1.43M$4.58M$3.44M$2.04M-$193.7K-$119.6K$3.06M$2.25M
Research and development$2.61M$2.51M$2.39M$3.25M$2.36M$1.40M$1.33M$1.42M$1.66M$2.01M
Selling, general and admin$6.28M$7.14M$7.86M$9.36M$6.03M$5.85M$5.04M$5.33M$5.68M$4.44M
Operating income-$6.83M-$4.01M-$8.83M-$9.92M-$4.94M-$5.20M-$1.07M$80-$4.28M-$4.20M
Interest expense$60.8K$175.8K$218.3K$10.5K$18.0K$4.34M$1.07M---
Pre-tax income-$7.14M-$4.32M-$8.66M-$11.93M$0-----
Income tax$16.5K-$23.0K-$134.0K-$20.4K$0$0$0$0$0-$12.1K
Net income-$7.16M-$4.30M-$8.52M-$11.91M-$5.07M-$9.67M-$14.59M-$6.87M-$4.28M-$4.19M
EPS, basic-$10.77-$20.88-$15.21-$27.26-$0.65-$2.08-$8.21-$5.84-$6.08-$7.12
EPS, diluted-----$0.65-$2.08-$8.21-$5.84-$6.08-$7.12
Diluted shares----7.8M4.7M1.8M1.5M829,797.75698,393

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Cash and equivalents$2.69M$437.6K$511.4K$2.64M$7.75M$16.99M$79.0K$323.9K$288.7K$1.06M
Receivables$1.22M$718.2K$1.20M$1.52M$970.6K$548.0K$126.0K$1.57M$2.88M$1.56M
Inventory$370.9K$378.3K$445.7K$4.43M$4.94M$330.9K$429.1K$998.8K$946.8K$465.4K
Current assets$4.54M$1.89M$2.62M$8.98M$14.01M$18.94M$1.37M$4.23M$7.01M$4.91M
Goodwill---$0$1.26M$1.26M----
Total assets$8.30M$8.62M$4.52M$11.34M$17.77M$22.52M$2.50M$11.69M$16.08M$17.29M
Current liabilities$3.10M$4.55M$3.21M$5.46M$2.00M$1.88M$4.39M$1.23M$2.33M$1.84M
Short-term debt--$138.7K$120.0K$0$232.0K----
Long-term debt-$44.8K$188.8K$326.8K$0-----
Total debt-$44.8K$327.5K$446.8K$0-----
Total liabilities$3.20M$4.84M$3.45M$6.04M$2.15M$2.19M$4.78M$1.23M$2.33M$1.84M
Shareholders' equity$5.11M$3.77M$1.06M$5.30M$15.62M$20.34M-$2.29M$10.47M$13.75M$15.45M

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Operating cash flow-$4.67M-$2.91M-$3.79M-$6.23M-$8.98M-$4.95M-$1.85M-$1.61M-$2.47M-$4.45M
Capital expenditures$12.0K$13.0K$1.0K$82.0K$42.0K$35.6K$28.8K$52.1K$166.1K$53.0K
Free cash flow-$4.68M-$2.93M-$3.79M-$6.31M-$9.02M-$4.99M-$1.88M-$1.67M-$2.63M-$4.50M
Investing cash flow-$12.0K-$13.0K-$1.0K-$696.6K-$42.0K-$2.23M-$543.3K-$82.5K-$226.8K-$53.0K
Financing cash flow$6.91M$2.83M$1.43M$1.90M-$218.6K$24.09M$2.15M$1.73M$1.92M$1.24M
Stock-based compensation-------$942.7K$940.7K$260.8K
Depreciation and amortization$84.5K$93.0K$75.1K$43.8K------

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue growth, YoY-14.3%-10.6%10.5%37.3%80.3%25.1%-43.9%-35.8%111.8%-43.4%
Gross margin76.9%81.4%18.5%65.2%67.3%72.0%-8.5%-3.0%48.6%75.5%
Operating margin-115.0%-57.9%-113.8%-141.4%-96.6%-183.4%-47.1%0.0%-67.8%-141.2%
Net margin-120.6%-62.1%-109.9%-169.7%-99.0%-341.0%-643.4%-169.8%-67.8%-140.8%
Free cash flow margin-78.8%-42.2%-48.9%-89.9%-176.4%-175.8%-82.9%-41.2%-41.8%-151.2%
Return on equity-140.2%-114.0%-801.3%-224.6%-32.4%-47.6%--65.6%-31.1%-27.1%
Return on assets-86.2%-49.9%-188.7%-105.0%-28.5%-43.0%-584.3%-58.7%-26.6%-24.2%
Current ratio1.470.410.821.657.0110.100.313.453.022.67
Debt to equity-0.010.310.080.00-----

Source: XBRL data BIO-key International Inc. files with the SEC, latest filing dated Aug 13, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures and share counts are restated for stock splits the filings show: 1-for-8, first reported Mar 29, 2021.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

BKYI peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
BKYI$6.70M-3.1%-$6.04M-90.1%$4.8M
MSFT$346.44B+17.9%$142.63B41.2%$3.94T
PLTR$7.29B+87.1%$3.67B50.3%$386.44B
ORCL$71.78B+21.6%$18.92B26.4%$351.04B
SAP€36.80B+7.7%€7.16B19.5%$286.79B
CRWD$5.40B+24.3%$58.46M1.1%$222.09B
SHOP$14.17B+32.5%$2.13B15.0%$191.58B
CRM$43.94B+11.2%$9.66B22.0%$175.83B
NOW$15.43B+21.8%$1.45B9.4%$105.84B

BKYI FAQ

8 questions
  • What is BKYI revenue?
    BIO-key International Inc. (BKYI) reported $6.70M of revenue for the twelve months ended Jun 30, 2026. That is down 3.1% from the year before. Revenue for fiscal 2025 was $5.94M.
  • Is BKYI profitable?
    No. BIO-key International Inc. reported a net loss of $6.04M for the twelve months ended Jun 30, 2026.
  • How much cash and debt does BKYI have?
    BIO-key International Inc. reported $1.38M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • How fast is BKYI revenue growing?
    BIO-key International Inc.'s revenue changed -14.3% in fiscal 2025, to $5.94M. Its compound annual growth rate was +15.9% over 5 years and +1.2% over 10 years.
  • What is BKYI gross margin?
    BIO-key International Inc.'s gross profit was $5.45M on $6.70M of revenue for the twelve months ended Jun 30, 2026, a gross margin of 81.3%.
  • What is BKYI free cash flow?
    BIO-key International Inc. generated -$4.16M of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of -$4.16M less capital expenditures.
  • When did BKYI last report financial results?
    The latest statements here come from BIO-key International Inc.'s 10-Q filed on Aug 13, 2026, covering the period ended Jun 30, 2026.
  • Where does this BKYI financial data come from?
    Quantisnow builds these statements from the structured XBRL data BIO-key International Inc. files with the SEC. It is provided for information only and is not investment advice.